Create New Account Purchaser Login
Search Tenders
Search
Advanced Search
You are not logged in.

Request of Proposals - Supply of Fluticasone and Fluticasone with Salmeterol Metered Dose Inhalers

Details

Tender Closed
RFx ID : 21314358
Tender Name : Request of Proposals - Supply of Fluticasone and Fluticasone with Salmeterol Metered Dose Inhalers
Reference # : A1283016
Open Date : Monday, 29 July 2019 4:00 PM (Pacific/Auckland UTC+12:00)
Close Date : Monday, 19 August 2019 5:00 PM (Pacific/Auckland UTC+12:00)
Tender Type : Request for Proposals (RFP)
Tender Coverage : Sole Agency  [?]
Categories :
  • 42000000 - Medical Equipment and Accessories and Supplies
  • 51000000 - Drugs and Pharmaceutical Products
Regions:
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Josh Wiles
josh.wiles@pharmac.govt.nz
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Overview

REQUEST FOR PROPOSALS - SUPPLY OF FLUTICASONE AND FLUTICASONE WITH SALMETEROL METERED DOSE INHALERS

PHARMAC invites proposals for the supply of fluticasone and fluticasone with salmeterol, metered dose inhalers (MDIs) in New Zealand.

This request for proposals (RFP) letter incorporates the following schedules:

· Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
· Schedule 4 contains the RFP form in which you are to provide details of your proposal.

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5:00 pm on 19 August 2019.

If you have any questions about this RFP, please post these on GETS. Responses to all questions will be published on GETS.

We look forward to receiving your proposal.